How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care?

LawSeq Quality Task Force

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Delivering high quality genomics-informed care to patients requires accurate test results whose clinical implications are understood. While other actors, including state agencies, professional organizations, and clinicians, are involved, this article focuses on the extent to which the federal agencies that play the most prominent roles - the Centers for Medicare and Medicaid Services enforcing CLIA and the FDA - effectively ensure that these elements are met and concludes by suggesting possible ways to improve their oversight of genomic testing.

Original languageEnglish (US)
Pages (from-to)44-68
Number of pages25
JournalThe Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
Volume48
Issue number1
DOIs
StatePublished - Mar 1 2020

PubMed: MeSH publication types

  • Journal Article

Fingerprint Dive into the research topics of 'How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care?'. Together they form a unique fingerprint.

  • Cite this